AI_PREMie (Artificial Intelligence to Prevent preterm birth due to preeclampsia while protecting Mothers’ lives), is a combination of patented biomarker testing and risk assessment powered by machine learning that not only accurately diagnoses preeclampsia but also predicts the patient’s outcome.
By combining the indications of P.E.T. that come from the novel biomarkers developed by the team and the in-depth patient information available in the hospitals, AI-PREMie can augment the intelligence of the clinician in real-time and help them make better decisions. This could reduce enormous risks for mothers and babies, facilitating early intervention before severe complications have occurred.
How does HEAnet support this?
HEAnet, through its partnership with GÉANT, has made a pan-European Infrastructure-as-a-Service (IaaS) framework available to all researchers in Ireland. The 2020 IaaS+ Framework is aimed at further accelerating the adoption of cloud services by research and education institutions.
Fred Clarke, Head of Research IT in UCD IT Services said “UCD IT Services partnership with HEAnet enabled the delivery of essential services to researchers. Thanks to HEAnet and GÉANT, researchers have now the tools they need and the ability to focus on their research without having to spend time in lengthy and complex procurements.”
Ronan Byrne, HEAnet’s Interim CEO commented “We would like to congratulate everyone involved in the AI_PREMie project. Our partnership with UCD IT Services is an excellent example of the positive impact that centralised purchasing can enable for the research community. HEAnet are looking forward to further supporting researchers in the future so they can continue tackling the grand challenges that we face in terms of climate, health, and societal wellbeing.”
Submitted by Barbara Carroll
